...期 超声观察了84例转移性肝癌在射频消融[1](radiofrequency ablation,RFA)联合瘤内注射无水乙醇(percutaneous ethanol injection,PEI)治疗前后肿瘤内血流的变化,以探讨彩色多普勒超声(CDFI)在RFA+PEI治疗转移性肝癌的临床价值。
基于4个网页-相关网页
穿刺瘤内注射无水乙醇 percutaneous ethanol injection
经皮化学灭活介入治疗肝癌主要有经皮无水乙醇瘤内注射(PEIT)和经皮乙酸注射(PAIT)两种。
Chemoablation of the liver cancer include both percutaneous ethanol injection therapy (PEIT) and percutaneous acetic acid injection therapy (PAIT).
目的探讨CT引导下经皮肝穿刺无水乙醇瘤内注射治疗原发性肝癌的疗效。
Objective To investigate effect of anhydrous ethanol tumor injection for primary liver cancer under the guide of ct.
目的：分析肝癌患者瘤内无水乙醇注射治疗（PEIT）疗效的影响因素，完善治疗技术。
PURPOSE:To analyze factors that affect percutaneous ethanol injection therapy (PEIT), in order to improve PEIT technology.
应用推荐